BRIEF-Agile therapeutics resubmits new drug application for transdermal contraceptive patch
* Agile therapeutics resubmits new drug application (NDA) for its transdermal contraceptive patch, Twirla®
SAO PAULO May 12 Brazil's Usinas Siderúrgicas de Minas Gerais SA implemented a 1 billion reais ($318.5 million) capital reduction in division Mineração Usiminas SA, or MUSA, the steelmaker said in a Friday securities filing.
Shareholders had approved the transaction on March 3. Usiminas, as the company is known, has been trying for months to tap excess cash from MUSA to comply with a debt refinancing accord with banks. The initiative was rejected in January by MUSA shareholder Sumitomo Corp. ($1 = 3.14 reais) (Reporting by Bruno Federowski; Editing by Chizu Nomiyama)
* Dimension Therapeutics completes strategic review and updates corporate priorities
June 27 U.S. stock index futures were lower on Tuesday as a selloff in technology shares continued, while investors awaited clues on interest rate hikes from Federal Reserve Chair Janet Yellen's talk in London.